"Nabi Tests Nicotine Vaccine"

Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.

 

------------------------------------------------------------

 

June 14, 2002

 

U.S. IMMUNIZATION NEWS

 

"Nabi Tests Nicotine Vaccine"

Fort Lauderdale Sun-Sentinel (www.sun-sentinel.com) (06/13/02) P. 2D; Singer, Glenn

 

Phase I clinical trials for Nabi Biopharmaceuticals' nicotine vaccine Nic-VAX will involve 20 nonsmoking, healthy volunteers in Pittsburgh.  If the vaccine is successful, the vaccine will then ask for Food and Drug Administration for permission to move onto phase II studies, where smokers would participate in a trial to determine if the drug is successful at treating addiction. Nic-VAX encourages the body to create antibodies to nicotine, which is highly addictive, that soak up nicotine before it reaches the brain, according to Nabi's vice president of quality, regulatory, and product development, Robert Nasco.  The Nic-VAX clinical trial is being funded by a $4 million grant from the National Institute on Drug Abuse.

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.